Dumping Syndrome Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The dumping syndrome market size has grown rapidly in recent years. It will grow from $1.24 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to gastric surgery procedures, increased prevalence of obesity, advancements in surgical techniques, improved diagnostic methods.

The dumping syndrome market size is expected to see strong growth in the next few years. It will grow to $2 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to weight loss surgery trends, personalized treatment approaches, nutritional and dietary interventions, telemedicine and remote monitoring. Major trends in the forecast period include minimally invasive surgical techniques, data analytics and ai, increased collaboration, preventive measures.

The increasing prevalence of upper gastrointestinal (GI) diseases is anticipated to be a significant driver for the growth of the dumping syndrome market in the coming years. Upper GI diseases pertain to disorders that affect the upper segment of the digestive system, encompassing the esophagus, stomach, and the initial section of the small intestine (duodenum). Dumping syndrome is a condition that can manifest after individuals undergo specific upper gastrointestinal (GI) surgeries, particularly those involving the stomach, duodenum, or pyloric sphincter. For instance, as of April 2023, the National Library of Medicine reported that upper gastrointestinal bleeding (UGIB) constitutes a prevalent issue, with an estimated incidence rate ranging from 80 to 150 cases per 100,000 individuals annually. Mortality rates are estimated to range from 2 to 15 percent, and UGIB accounts for 75% of all cases of acute gastrointestinal (GI) bleeding. Consequently, the increasing prevalence of upper GI diseases stands as a driving force behind the growth of the dumping syndrome market.

Increasing investment in the healthcare sector is expected to support the growth of the dumping syndrome market. Healthcare infrastructure encompasses spending on medical care, preventive services, public health initiatives, rehabilitation, community health activities, and medical research. This spending is crucial for advancing dumping syndrome treatments by enabling access to a range of medical diagnoses and therapies. For example, in July 2024, the American Medical Association reported that U.S. health spending in 2022 rose by 4.1%, totaling $4.5 trillion, which amounts to $13,493 per person. Consequently, rising healthcare sector investment is contributing to growth in the dumping syndrome market.

Key players in the Dumping Syndrome market are focused on developing innovative solutions, such as bariatric surgery, to enhance patient outcomes. Bariatric surgery encompasses various procedures designed to help individuals with obesity achieve significant weight loss. For example, in May 2024, Blackrock WeightCare, a weight loss service based in Ireland, introduced the Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S). This cutting-edge surgery combines sleeve gastrectomy with a partial intestinal bypass, providing an effective treatment for patients with severe obesity, particularly those with a BMI over 45. The SADI-S procedure, which uses robotic technology, is expected to deliver improved weight loss results while reducing complications like dumping syndrome. Additionally, Blackrock WeightCare offers comprehensive aftercare to ensure long-term patient success.

Leading companies in the dumping syndrome market are focusing on advancing endoscopy services, including the use of AI-supported equipment, to improve examination accuracy and patient comfort. For example, in January 2024, Docrates Cancer Center, a private hospital in Finland, introduced gastrointestinal endoscopy services. This initiative aims to meet the growing demand for early cancer detection and diagnostic exams, specifically for the esophagus, stomach, and colon. The service features thorough examinations enhanced by AI technology to support more precise diagnostics.

Major companies operating in the dumping syndrome market are Cardinal Health Inc., Johnson & Johnson Private Limited, Abbott Laboratories Inc., Medtronic PLC, Covidien PLC, Fujifilm Holdings Corporation, Stryker Corporation, Allergan PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Terumo Corporation, Steris Corporation, Teleflex Medical Europe Ltd., Cook Medical Inc., Karl Storz SE & Co. KG, Conmed Corporation, Applied Medical Resources Corporation, Richard Wolf GmbH, Pentax Medical Company, GI Dynamics, EndoGastric Solutions Inc., Apollo Endosurgery Inc., EndoChoice Holdings Inc., Cousin Biotech, Mediflex Surgical Product, Asensus Surgical Inc., USGI Medical Inc., TransEnterix Inc.

North America was the largest region in the dumping syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dumping syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the dumping syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dumping syndrome market consists of revenues earned by entities by providing endoscopy, surgical interventions and dietary services. The market value includes the value of related goods sold by the service provider or included within the service offering. The dumping syndrome market also includes sales of Acarbose and Octreotide drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Dumping syndrome, also referred to as rapid gastric emptying, is a medical condition characterized by the swift emptying of the stomach's contents into the small intestine. This often results in uncomfortable, and in some cases, severe symptoms. It is commonly observed following specific stomach surgeries, particularly gastric bypass or partial gastrectomy.

The primary types of diagnoses for dumping syndrome encompass blood sugar tests, gastric emptying tests, and medical histories, among others. A blood sugar test, also known as a blood glucose test, is a medical examination utilized to gauge the concentration of glucose (sugar) in an individual's bloodstream. Treatment options encompass medication, surgery, and other modalities, which can be administered through various routes like oral, intravenous, and others. These treatments are employed to address different phases of the condition, including both the early and late dumping phases. The services are availed by a range of end-users, including hospitals, clinics, research laboratories, and others.

The dumping syndrome market research report is one of a series of new reports that provides dumping syndrome market statistics, including dumping syndrome industry global market size, regional shares, competitors with a dumping syndrome market share, detailed dumping syndrome market segments, market trends and opportunities and any further data you may need to thrive in the dumping syndrome industry. This dumping syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.